Company / Return on Assets (ROA)
AVADEL PHARMACEUTICALS PLC Return on Assets (ROA) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-29.7%
FY2024
5-year range
-103.5% / 2.3%
FY2020-FY2024
Trend
+69.5%
vs FY2023
Sector context
#131 of 213
Health Care
What the data says
At -29.7%, AVADEL PHARMACEUTICALS PLC's return on assets (roa) ranks #131 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -103.5% in FY2022 to 27.0% in FY2017.
Based on SEC 10-K filings.
-29.7% in FY2024 with a 5-year CAGR of -7.8%.
Improved from -103.5% to -29.7% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +1.5pp
- 5-Year Change
- -7.8pp
- 10-Year Change
- -
Sector benchmark
#131 of 213 in Health CareTop 62% of 213This company -29.7% Sector average -24.1%
▼
-23.2% below sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 69.5% year-over-year.
- Currently 5.6pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -29.7% | +69.5% |
| FY2023 | -97.3% | +6.0% |
| FY2022 | -103.5% | -231.1% |
| FY2021 | -31.3% | -1483.6% |
| FY2020 | 2.3% | +110.3% |
| FY2019 | -21.9% | +56.2% |
| FY2018 | -50.1% | -285.8% |
| FY2017 | 27.0% | +260.4% |
| FY2016 | -16.8% | -186.5% |
| FY2015 | 19.4% | +139.6% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026